| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.27 | 3e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.26 | 7e-07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.45 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |